Skip to main content
Tech.euFundingExplorerBeta

IMU Biosciences

IMU Biosciences is coupling deep, systems-level immune profiling with a proprietary AI platform to build a uniquely detailed immune atlas spanning the breadth of human health and disease

Total raised
€59M
€58,984,509
Funding rounds
2
Investors
2
distinct backers
Active since
2024-01
latest 2026-06

Funding by year

EUR raised per year · 2026 YTD

Signals

High confidence
Raise-next likelihood21
base rate 30% for Other
  • Raised very recently
  • Up-round momentum
  • Low backer re-investment
Exit likelihood11
base rate 12% (2+ rounds)
  • €30M+ raised
  • Young (<3y)

Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

2 rounds
DateStageAmountInvestors
2026-06-02Other€46MIQ Capital,Molten VenturesView deal →
2024-01-24Series A€13MMolten VenturesView deal →

Similar companies

same sector or country
  • Nscale
    UK · Cloud
    €5.0B
  • Arm
    UK · Semiconductors
    €4.7B
  • DAZN
    UK · Software
    €3.8B
  • SumUp
    UK · Fintech
    €3.5B
  • CityFibre
    UK · Telecom
    €3.0B
  • Philips
    Netherlands · Healthtech
    €2.6B